Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function

Journal of Clinical Investigation

Volumn 117, Issue 2, 2007, Pages 464-472

  Idzko, Marco ^a,b   Hammad, Hamida ^a   Van Nimwegen, Menno ^a   Kool, Mirjam ^a   Vos, Nanda ^a   Hoogsteden, Henk C ^a   Lambrecht, Bart N ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; ASTHMA; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MECHANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CELL DIFFERENTIATION; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; ILOPROST; LUNG; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; TH2 CELLS;

EID: 33846846677     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28949     Document Type: Article

References (56)

1. Park, G.Y., and Christman, J.W. 2006. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol. Lung Cell Mol. Physiol. 290:L797-L805.
2. Liu, M.C., et al. 1990. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am. Rev. Respir. Dis. 142:126-132.
3. Dahlen, S.E., et al. 1983. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Proc. Natl. Acad. Sci. U. S. A. 80:1712-1716.
4. Carey, M.A., Germolec, D.R., Langenbach, R., and Zeldin, D.C. 2003. Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot. Essent. Fatty Acids. 69:157-162.
5. Warner, T.D., and Mitchell, J.A. 2004. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 18:790-804.
6. Helliwell, R.J., Adams, L.F., and Mitchell, M.D. 2004. Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukot. Essent. Fatty Acids. 70:101-113.
7. Kunikata, T., et al. 2005. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat. Immunol. 6:524-531.
8. Jaffar, Z., Wan, K.S., and Roberts, K. 2002. A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J. Immunol. 169:5997-6004.
9. Gavett, S.H., et al. 1999. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J. Clin. Invest. 104:721-732.
10. Peebles, R.S., Jr., et al. 2000. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. Am. J. Respir. Crit. Care Med. 162:676-681.
11. Walmrath, D., et al. 1991. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. J. Appl. Physiol. 71:2499-2506.
12. Schulman, E.S., Newball, H.H., Demers, L.M., Fitzpatrick, F.A., and Adkinson, N.F., Jr. 1981. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am. Rev. Respir. Dis. 124:402-406.
13. Takahashi, Y., et al. 2002. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137:315-322.
14. Nagao, K., et al. 2003. Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am. J. Respir. Cell Mol. Biol. 29:314-320.
15. Hoeper, M.M., et al. 2000. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N. Engl. J. Med. 342:1866-1870.
16. Banchereau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
17. Lambrecht, B.N., and Hammad, H. 2003. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat. Rev. Immunol. 3:994-1003.
18. Lambrecht, B.N., et al. 2000. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 106:551-559.
19. Vermaelen, K.Y., Carro-Muino, I., Lambrecht, B.N., and Pauwels, R.A. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:51-60.
20. Eisenbarth, S.C., et al. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645-1651.
21. Lambrecht, B.N., Salomon, B., Klatzmann, D., and Pauwels, R.A. 1998. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J. Immunol. 160:4090-4097.
22. van Rijt, L.S., et al. 2005. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201:981-991.
23. Clark, R.D., et al. 2004. Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists [corrected]. Bioorg. Med. Chem. Lett. 14:1053-1056.
24. Morelli, A.E., and Thomson, A.W. 2003. Dendritic cells under the spell of prostaglandins. Trends Immunol. 24:108-111.
25. van Rijt, L.S., et al. 2002. Allergen-induced accumulation of airway dendritic cells is supported by an increase in CD31(hi)Ly-6C(neg) bone marrow precursors in a mouse model of asthma. Blood. 100:3663-3671.
26. Vermaelen, K., and Pauwels, R. 2003. Accelerated airway dendritic cell maturation, trafficking, and elimination in a mouse model of asthma. Am. J. Respir. Cell Mol. Biol. 29:405-409.
27. Huh, J.C., et al. 2003. Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J. Exp. Med. 198:19-30.
28. Lewkowich, I.P., et al. 2005. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202:1549-1561.
29. Martin-Fontecha, A., et al. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198:615-621.
30. de Heer, H.J., et al. 2004. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200:89-98.
31. Marcinkiewicz, J., and Chain, B.M. 1993. Differential cytokine regulation by eicosanoids in T cells primed by contact sensitisation with TNP. Cell. Immunol. 149:303-314.
32. Della Bella, S., et al. 1997. Differential effects of cyclo-oxygenase pathway metabolites on cytokine production by T lymphocytes. Prostaglandins Leukot. Essent. Fatty Acids. 56:177-184.
33. Costantini, V., et al. 1990. Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice. Prostaglandins. 39:581-599.
34. Depuydt, P.O., Lambrecht, B.N., Joos, G.F., and Pauwels, R.A. 2002. Effect of ozone exposure on allergic sensitization and airway inflammation induced by dendritic cells. Clin. Exp. Allergy. 32:391-396.
35. Czeslick, E.G., Simm, A., Grond, S., Silber, R.E., and Sablotzki, A. 2003. Inhibition of intracellular tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 production in human monocytes by iloprost. Eur. J. Clin. Invest. 33:1013-1017.
36. Muzaffar, S., Shukla, N., Lobo, C., Angelini, G.D., and Jeremy, J.Y. 2004. Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery. Br. J. Pharmacol. 141:488-496.
37. Mazzone, A., et al. 2002. Effects of iloprost on adhesion molecules and F1 + 2 in peripheral ischemia. Eur. J. Clin. Invest. 32:882-888.
38. Jozefowski, S., Bobek, M., and Marcinkiewicz, J. 2003. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved. Int. Immunopharmacol. 3:865-878.
39. Rose, F., et al. 2003. Increased neutrophil mediator release in patients with pulmonary hypertension - suppression by inhaled iloprost. Thromb. Haemost. 90:1141-1149.
40. Boehme, M.W., Gao, I.K., Norden, C., and Lemmel, E.M. 2006. Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results. Rheumatol. Int. 26:340-347.
41. Gao, I.K., Scholz, P., Boehme, M.W., Norden, C., and Lemmel, E.M. 2002. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects. Rheumatol. Int. 22:45-51.
42. Barnes, P.J. 2004. New drugs for asthma. Nat. Rev. Drug Discov. 3:831-844.
43. Lellouch-Tubiana, A., Lefort, J., Simon, M.T., Pfister, A., and Vargaftig, B.B. 1988. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Am. Rev. Respir. Dis. 137:948-954.
44. Kohl, J., et al. 2006. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 116:783-796. doi:10.1172/JCI26582.
45. Zhou, B., et al. 2005. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 6:1047-1053.
46. van Rijt, L.S., et al. 2004. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma. J. Allergy Clin. Immunol. 114:166-173.
47. Zinser, E., Lechmann, M., Golka, A., Lutz, M.B., and Steinkasserer, A. 2004. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 200:345-351.
48. Harris, N.L., Watt, V., Ronchese, F., and Le Gros, G. 2002. Differential T cell function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 195:317-326.
49. Hammad, H., et al. 2002. Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J. Immunol. 169:1524-1534.
50. Sanchez-Sanchez, N., Riol-Blanco, L., and Rodriguez-Fernandez, J.L. 2006. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol. 176:5153-5159.
51. Serbina, N.V., Salazar-Mather, T.P., Biron, C.A., Kuziel, W.A., and Pamer, E.G. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 19:59-70.
52. van Rijt, L.S., et al. 2004. A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J. Immunol. Methods. 288:111-121.
53. Hamelmann, E., et al. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766-775.
54. Hantos, Z., Daroczy, B., Suki, B., Nagy, S., and Fredberg, J.J. 1992. Input impedance and peripheral inhomogeneity of dog lungs. J. Appl. Physiol. 72:168-178.
55. Fredberg, J.J., and Stamenovic, D. 1989. On the imperfect elasticity of lung tissue. J. Appl. Physiol. 67:2408-2419.
56. Collins, R.A., et al. 2005. Hyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in mice. Respir. Res. 6:142.